TRT isn't just about gains: what low testosterone actually means

What's this video probably claiming?

Based on the caption, @codybobay appears to be pushing back against the bodybuilding-bro image of testosterone replacement therapy, arguing that medically prescribed TRT is about restoring normal hormone levels in men with genuine deficiency, not about packing on muscle. The creator is likely pointing out that a lot of men quietly experience fatigue, low libido, brain fog, and mood changes, and chalk it up to stress or aging rather than considering that their testosterone levels might actually be clinically low. This is a responsible framing, broadly speaking. The distinction between therapeutic TRT for diagnosed hypogonadism and the performance-enhancement world is a real and important one. Whether the creator accurately describes what "normal" levels look like, how deficiency is diagnosed, or what realistic treatment outcomes are, is where things could get more complicated.

What does the science actually show?

Hypogonadism, defined clinically as a total testosterone level below 300 ng/dL on two morning measurements, affects roughly 2-4% of men by strict diagnostic criteria, though some estimates using broader cutoffs run higher. The landmark Testosterone Trials (Snyder et al., 2016, New England Journal of Medicine), a coordinated set of seven placebo-controlled trials in men 65 and older with confirmed low testosterone, found modest but real improvements in sexual function and some benefit for bone density. Energy and mood improvements were less consistent. The TTrials also showed increased coronary artery noncalcified plaque volume in the TRT group, which raised legitimate cardiovascular questions that still haven't been fully resolved. A 2023 JAMA paper by Lincoff et al. on the TRAVERSE trial, following roughly 5,200 men for about 33 months, found TRT did not significantly increase major adverse cardiac events compared to placebo, though it did raise rates of pulmonary embolism and atrial fibrillation. These are not side effects to wave away.

Where does the social media noise diverge from clinical reality?

The biggest distortion isn't that TRT gets framed as being about gains, though that's real. It's that symptoms alone are being used as a diagnostic substitute. Fatigue, low libido, and mood changes are nonspecific. They overlap with depression, sleep apnea, obesity, thyroid dysfunction, and a dozen other conditions. The Endocrine Society guidelines are clear: symptoms plus confirmed low testosterone on lab work, not symptoms alone, are required for a diagnosis. A 2020 study by Handelsman in the Journal of Clinical Endocrinology and Metabolism flagged that direct-to-consumer testosterone clinics are frequently prescribing based on symptoms or borderline labs without following diagnostic protocols. TRT also suppresses endogenous testosterone production and can cause infertility through suppression of the hypothalamic-pituitary-gonadal axis. Men who want to preserve fertility need to know this before starting. Social media rarely leads with that.

What should you actually know?

If you're a man experiencing persistent fatigue, reduced libido, or mood changes, getting your testosterone checked is reasonable. But the test matters. Total testosterone should be drawn in the morning, fasting if possible, and a single low result should be repeated. Free testosterone and SHBG levels add context. If you genuinely have hypogonadism confirmed on lab work, TRT delivered through a regulated telehealth platform with proper monitoring, including hematocrit checks, since TRT raises red blood cell count, and PSA screening for men over 40, is a legitimate medical intervention. Expect realistic outcomes: improvements in sexual function and energy are documented, but TRT is not a body composition drug at therapeutic doses, and it comes with real monitoring requirements. The TRAVERSE trial's findings on pulmonary embolism and atrial fibrillation mean cardiovascular history should be part of any intake evaluation, not a checkbox afterthought.